Ancestim (stem cell factor, SCF) in combination with filgrastim can mobilize sufficient peripheral blood progenitor cells (PBPC) to support high-dose salvage chemotherapy and late intensification in relapsing and refractory aggressive non-Hodgkin's lymphoma. A GELA study.

Haioun, C.; Ferrant, Augustin; Van Hoof, A.; Thieblemont, C; Hulin, C.; Mounier, N.; Tilly, H.; Sebban, C.; Allain, A; Lepage, E.; Osselaer, Jean-Claude; Beaujean, F; Vannerom, H; Cailliot, C; Bosly, André

Ancestim (stem cell factor, SCF) in combination with filgrastim can mobilize sufficient peripheral blood progenitor cells (PBPC) to support high-dose salvage chemotherapy and late intensification in relapsing and refractory aggressive non-Hodgkin's lymphoma. A GELA study.

Haioun, C.

;

Ferrant, Augustin

;

Van Hoof, A.

;

Thieblemont, C

;

Bosly, André

;et.al.

(2003) 45th Annual Meeting of the American-Society-of-Hematology — Location: SAN DIEGO (California) (6.December.2003)

Files

No attached file found for this publication.

Details

Authors

Haioun, C.
Author
Ferrant, AugustinUCLouvain
Author
Van Hoof, A.
Author
Thieblemont, C
Author
Osselaer, Jean-ClaudeUCLouvain
Author
Bosly, AndréUCLouvain
Author

Affiliations

Citations

APA
Chicago
FWB

Haioun, C., Ferrant, A., Van Hoof, A., Thieblemont, C., Hulin, C., Mounier, N., Tilly, H., Sebban, C., Allain, A., Lepage, E., Osselaer, J.-C., Beaujean, F., Vannerom, H., Cailliot, C., & Bosly, A. (2003). Ancestim (stem cell factor, SCF) in combination with filgrastim can mobilize sufficient peripheral blood progenitor cells (PBPC) to support high-dose salvage chemotherapy and late intensification in relapsing and refractory aggressive non-Hodgkin’s lymphoma. A GELA study. Blood, 102(11), 415B-415B. https://hdl.handle.net/2078.5/141270 (Original work published 2003)